3,098 reports of this reaction
2.4% of all LAMOTIRIGINE reports
#5 most reported adverse reaction
DRUG INTERACTION is the #5 most commonly reported adverse reaction for LAMOTIRIGINE, manufactured by Actavis Pharma, Inc.. There are 3,098 FDA adverse event reports linking LAMOTIRIGINE to DRUG INTERACTION. This represents approximately 2.4% of all 130,106 adverse event reports for this drug.
Patients taking LAMOTIRIGINE who experience drug interaction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INTERACTION is a less commonly reported adverse event for LAMOTIRIGINE, but still significant enough to appear in the safety profile.
In addition to drug interaction, the following adverse reactions have been reported for LAMOTIRIGINE:
The following drugs have also been linked to drug interaction in FDA adverse event reports:
DRUG INTERACTION has been reported as an adverse event in 3,098 FDA reports for LAMOTIRIGINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INTERACTION accounts for approximately 2.4% of all adverse event reports for LAMOTIRIGINE, making it a notable side effect.
If you experience drug interaction while taking LAMOTIRIGINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.